23.12.2014 • NewsS&W Seed CompanyS&WDuPont

S&W to Buy DuPont Pioneer Alfalfa Seed Business

In a potential two-stage deal, S&W Seed Company, which describes itself as the world's largest "non-dormant" alfalfa seed company, plans to acquire all of DuPont Pioneer's alfalfa production and research facilities assets, along with its conventional (non-GMO) alfalfa germplasm, for up to $49 million.

Closing of the first stage is expected to take place this year, provided all closing conditions including financing are met. DuPont Pioneer would continue to distribute the products up to 2024.

Terms of this stage foresee California-based S&W paying the DuPont-Pioneer joint venture $27 million in cash up front in addition to a promissory note in the principal amount of $10 million payable on Dec. 31, 2017.

The purchase price also includes a potential earn-out payment of up to $5 million based on sales of the acquired germplasm in the three years following the closing.

S&W, which said the transaction would make it world's largest producer of alfalfa seed, has also agreed - contingent on satisfaction of certain conditions - to purchase DuPont Pioneer's GMO alfalfa germplasm and related assets for an additional $7 million in cash by Dec. 29, 2017.

If this second stage is completed, the total purchase price for would rise to as much $49 million.

S&W's CEO Mark Grewal said the deal, which will join the largest "non-dormant" alfalfa seed company in the world and one of the leaders in the "dormant" alfalfa seed market, includes 15 seed varieties currently on the market and 60 in the pipeline.

Facilities to be acquired include a seed cleaning and production facility in Nampa, Idaho, USA and research facilities in Arlington, Wisconsin. Some 31 employees of the DuPont alfalfa group will be offered jobs with the new owner.

Future operations will span the alfalfa seed production regions of California's San Joaquin and Imperial valleys, five other US states, Australia, and three Canadian provinces.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.